No significant weaknesses identified
| Name | Market Cap | Current Price | P/E Ratio | Revenue Growth 1Y | Net Margin | ROE | FCF Yield | Debt/Equity |
|---|---|---|---|---|---|---|---|---|
| UHTUniversal Health Realty Income Trust | 555.5M | 40.04 | 28.81 | 3.6% | 18.06% | 11.32% | 8.44% | 2.11 |
| MPWMedical Properties Trust, Inc. | 3.1B | 5.16 | -1.28 | 14.19% | -75.5% | -15.18% | 7.91% | 1.86 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 441.88M | 541.14M | 704.75M | 784.52M | 870.25M | 1.25B | 1.54B | 1.54B | 871.8M | 995.55M |
| Revenue Growth % | 0.41% | 0.22% | 0.3% | 0.11% | 0.11% | 0.44% | 0.24% | -0% | -0.43% | 0.14% |
| Property Operating Expenses | 3.79M | 2.71M | 5.81M | 9.24M | 23.99M | 24.89M | 39.1M | 45.7M | 41.57M | 27.25M |
| Net Operating Income (NOI) | - | - | - | - | - | - | - | - | - | - |
| NOI Margin % | - | - | - | - | - | - | - | - | - | - |
| Operating Expenses | 174.85M | 196.79M | 213.35M | 775.28M | 96.41M | 1.22B | 466.89M | 493.47M | 748.95M | 581.45M |
| G&A Expenses | 43.64M | 48.91M | 58.6M | 81M | 96.41M | 131.66M | 145.64M | 160.49M | 145.59M | 133.79M |
| EBITDA | 335.06M | 439.24M | 617.56M | 702.69M | 906.42M | 1.1B | 1.37B | 1.35B | 697.41M | 840.6M |
| EBITDA Margin % | - | - | - | - | - | - | - | - | - | - |
| Depreciation & Amortization | 71.83M | 97.6M | 131.98M | 141.49M | 156.57M | 275.95M | 333.78M | 345.58M | 616.13M | 453.75M |
| D&A / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Operating Income | 263.24M | 341.64M | 485.58M | 561.2M | 749.85M | 0 | 1.04B | 1B | 81.28M | 386.85M |
| Operating Margin % | - | - | - | - | - | - | - | - | - | - |
| Interest Expense | 120.88M | 159.6M | 176.95M | 223.27M | 237.83M | 356.91M | 395.04M | 368.49M | 410.89M | 422.12M |
| Interest Coverage | 2.18x | 2.14x | 2.74x | 2.51x | 3.15x | - | 2.63x | 2.72x | 0.20x | 0.92x |
| Non-Operating Income | 924K | -37.07M | -29.64M | 0 | 152.31M | -828.44M | 0 | 0 | 0 | 0 |
| Pretax Income | 141.43M | 219.11M | 293.92M | 1.02B | 373.78M | 463.33M | 730.89M | 959.72M | -686.77M | -2.36B |
| Pretax Margin % | - | - | - | - | - | - | - | - | - | - |
| Income Tax | 1.5M | -6.83M | 2.68M | 927K | -2.62M | 31.06M | 73.95M | 55.9M | -130.68M | 44.1M |
| Effective Tax Rate % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 139.6M | 225.05M | 289.79M | 1.02B | 374.68M | 431.45M | 656.02M | 902.6M | -556.48M | -2.41B |
| Net Margin % | - | - | - | - | - | - | - | - | - | - |
| Net Income Growth % | 1.76% | 0.61% | 0.29% | 2.51% | -0.63% | 0.15% | 0.52% | 0.38% | -1.62% | -3.33% |
| Funds From Operations (FFO) | - | - | - | - | - | - | - | - | - | - |
| FFO Margin % | - | - | - | - | - | - | - | - | - | - |
| FFO Growth % | 1% | 0.53% | 0.31% | 1.75% | -0.54% | 0.33% | 0.4% | 0.26% | -0.95% | -33.8% |
| FFO per Share | - | - | - | - | - | - | - | - | - | - |
| FFO Payout Ratio % | - | - | - | - | - | - | - | - | - | - |
| EPS (Diluted) | 0.63 | 0.86 | 0.82 | 2.76 | 0.87 | 0.81 | 1.11 | 1.50 | -0.93 | -4.02 |
| EPS Growth % | 1.17% | 0.37% | -0.05% | 2.37% | -0.68% | -0.07% | 0.37% | 0.35% | -1.62% | -3.32% |
| EPS (Basic) | 0.64 | 0.86 | 0.82 | 2.77 | 0.87 | 0.81 | 1.11 | 1.50 | -0.93 | -4.02 |
| Diluted Shares Outstanding | 218.3M | 261.07M | 350.44M | 366.27M | 428.3M | 530.46M | 590.14M | 598.84M | 598.52M | 600.32M |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total Assets | 5.61B | 6.42B | 9.02B | 8.84B | 14.47B | 16.83B | 20.52B | 19.66B | 18.3B | 14.29B |
| Asset Growth % | 0.5% | 0.14% | 0.41% | -0.02% | 0.64% | 0.16% | 0.22% | -0.04% | -0.07% | -0.22% |
| Real Estate & Other Assets | 4.9B | -4.46B | -6.12B | -6.44B | 1.48B | 416.2M | 450.43M | 14.99B | 13.65B | 11.38B |
| PP&E (Net) | 2.81B | 3.73B | 4.95B | 4.45B | 6.99B | 10.06B | 11.8B | 0 | 0 | 0 |
| Investment Securities | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Total Current Assets | 324.63M | 257.8M | 436.03M | 1.07B | 4.51B | 4.04B | 4.55B | 1.72B | 1.4B | 1.31B |
| Cash & Equivalents | 195.54M | 83.24M | 171.47M | 820.87M | 1.46B | 549.88M | 459.23M | 235.67M | 250.02M | 332.33M |
| Receivables | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Other Current Assets | 0 | 0 | 0 | 0 | 625.31M | 938.08M | 1.25B | 0 | 0 | 0 |
| Intangible Assets | 256.95M | 296.18M | 443.13M | 403.14M | 556.66M | 1.19B | 1.28B | 0 | 0 | 0 |
| Total Liabilities | 3.5B | 3.17B | 5.19B | 4.28B | 7.44B | 9.49B | 12.07B | 11.06B | 10.67B | 9.46B |
| Total Debt | 3.34B | 2.94B | 4.96B | 4.06B | 7.11B | 9.01B | 11.37B | 10.41B | 10.22B | 8.98B |
| Net Debt | 3.14B | 2.85B | 4.78B | 3.24B | 5.65B | 8.46B | 10.91B | 10.18B | 9.97B | 8.64B |
| Long-Term Debt | 2.22B | 2.62B | 4.06B | 4.04B | 7.02B | 8.87B | 11.28B | 9.34B | 8.55B | 8.49B |
| Short-Term Borrowings | 1000K | 320K | 0 | 0 | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K |
| Capital Lease Obligations | 12.83M | 28.32M | 57.05M | 27.52M | 78.28M | 91.94M | 87.15M | 146.13M | 156.6M | 129.04M |
| Total Current Liabilities | 166.71M | 227.64M | 229.37M | 217.79M | 291.49M | 438.75M | 607.79M | 1.58B | 1.96B | 845.38M |
| Accounts Payable | 134.46M | 174.56M | 211.19M | 246.7M | 285.89M | 387.45M | 603.59M | 0 | 0 | 0 |
| Deferred Revenue | 29.36M | 19.93M | 18.18M | 13.47M | 0 | 0 | 0 | 27.73M | 37.96M | 29.45M |
| Other Liabilities | 1.1B | 290M | 840.81M | 0 | 45.72M | 89.01M | 96.41M | 0 | 0 | 0 |
| Total Equity | 2.11B | 3.25B | 3.84B | 4.56B | 7.03B | 7.34B | 8.45B | 8.59B | 7.63B | 4.83B |
| Equity Growth % | 0.52% | 0.54% | 0.18% | 0.19% | 0.54% | 0.04% | 0.15% | 0.02% | -0.11% | -0.37% |
| Shareholders Equity | 2.1B | 3.25B | 3.82B | 4.55B | 7.03B | 7.34B | 8.44B | 8.59B | 7.63B | 4.83B |
| Minority Interest | 5M | 4.85M | 14.57M | 13.83M | 107K | 5.33M | 5.48M | 1.57M | 2.27M | 1.05M |
| Common Stock | 237K | 321K | 364K | 371K | 518K | 541K | 597K | 597K | 599K | 600K |
| Additional Paid-in Capital | 2.59B | 3.78B | 4.33B | 4.44B | 7.01B | 7.46B | 8.56B | 8.54B | 8.56B | 8.58B |
| Retained Earnings | -418.65M | -434.11M | -485.93M | 162.77M | 83.01M | 0 | -87.69M | 116.28M | -971.81M | -3.66B |
| Preferred Stock | 0 | 0 | 49K | 202K | 0 | 0 | 0 | 0 | 0 | 0 |
| Return on Assets (ROA) | 0.03% | 0.04% | 0.04% | 0.11% | 0.03% | 0.03% | 0.04% | 0.04% | -0.03% | -0.15% |
| Return on Equity (ROE) | 0.08% | 0.08% | 0.08% | 0.24% | 0.06% | 0.06% | 0.08% | 0.11% | -0.07% | -0.39% |
| Debt / Assets | 0.59% | 0.46% | 0.55% | 0.46% | 0.49% | 0.54% | 0.55% | 0.53% | 0.56% | 0.63% |
| Debt / Equity | 1.58x | 0.90x | 1.29x | 0.89x | 1.01x | 1.23x | 1.35x | 1.21x | 1.34x | 1.86x |
| Net Debt / EBITDA | 9.37x | 6.50x | 7.75x | 4.62x | 6.23x | 7.66x | 7.95x | 7.54x | 14.30x | 10.28x |
| Book Value per Share | 9.65 | 12.46 | 10.94 | 12.45 | 16.41 | 13.84 | 14.31 | 14.35 | 12.75 | 8.05 |
| Dec 2015 | Dec 2016 | Dec 2017 | Dec 2018 | Dec 2019 | Dec 2020 | Dec 2021 | Dec 2022 | Dec 2023 | Dec 2024 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Cash from Operations | 207M | 264.68M | 363.1M | 449.09M | 494.12M | 617.64M | 811.66M | 739.01M | 505.79M | 245.48M |
| Operating CF Growth % | 0.38% | 0.28% | 0.37% | 0.24% | 0.1% | 0.25% | 0.31% | -0.09% | -0.32% | -0.51% |
| Operating CF / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Net Income | 139.93M | 225.94M | 291.24M | 1.02B | 376.4M | 432.27M | 656.94M | 903.82M | -556.09M | -2.41B |
| Depreciation & Amortization | 71.83M | 97.6M | 131.98M | 141.49M | 156.57M | 275.95M | 333.78M | 345.58M | 616.13M | 453.75M |
| Stock-Based Compensation | 11.12M | 7.94M | 9.95M | 16.5M | 32.19M | 47.15M | 52.11M | 49.42M | 33.25M | 32.98M |
| Other Non-Cash Items | -27.29M | -13.91M | -37.51M | -79M | -103.64M | -176.8M | -287.04M | -600.09M | 563.12M | 2.18B |
| Working Capital Changes | 14.68M | 1.11M | -25.12M | 23M | 53.13M | 17.22M | 13.12M | 29.59M | 16.72M | -15.6M |
| Cash from Investing | -1.95B | -926.54M | -2.36B | 564.18M | -4.88B | -2.95B | -3.86B | 396.06M | 517.56M | 1.32B |
| Acquisitions (Net) | -2.22B | -1.68B | -2.25B | -1.43B | -4.57B | -4.18B | -5.28B | -1.32B | -222.76M | -93.96M |
| Purchase of Investments | -17.34M | -119.42M | -94.97M | -138.44M | -293.16M | -36.18M | -289.24M | -207.39M | -294.17M | -500.11M |
| Sale of Investments | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 1000K | 0 | 1000K |
| Other Investing | 290.59M | 797.73M | -20.31M | 2.13B | 4.72B | 4.09B | 1.72B | 3.45B | 1.03B | 93.96M |
| Cash from Financing | 1.8B | 552.56M | 2.07B | -345.87M | 5.04B | 1.4B | 2.95B | -1.34B | -1.02B | -1.48B |
| Dividends Paid | -182.98M | -218.39M | -326.73M | -363.91M | -411.7M | -567.97M | -643.47M | -698.53M | -615.39M | -321.08M |
| Common Dividends | -182.98M | -218.39M | -326.73M | -363.91M | -411.7M | -567.97M | -643.47M | -698.53M | -615.39M | -321.08M |
| Debt Issuance (Net) | 1000K | -1000K | 1000K | -1000K | 1000K | 1000K | 1000K | -1000K | -1000K | 1000K |
| Share Repurchases | 0 | 0 | 0 | 0 | 0 | 0 | 0 | -17.94M | 0 | -3.81M |
| Other Financing | -23.85M | 1.16B | -18.25M | -24.22M | -62.32M | -20.64M | -36.67M | -88.55M | 15.31M | -1.26B |
| Net Change in Cash | 51M | -112.3M | 88.23M | 650.18M | 645.57M | -911.62M | -94.49M | -220.34M | 14.41M | 79.22M |
| Exchange Rate Effect | -1000K | -1000K | 1000K | -1000K | -1000K | 1000K | 1000K | -1000K | 1000K | -1000K |
| Cash at Beginning | 144.54M | 195.54M | 83.24M | 172.25M | 822.42M | 1.47B | 556.37M | 461.88M | 241.54M | 255.95M |
| Cash at End | 195.54M | 83.24M | 171.47M | 822.42M | 1.47B | 556.37M | 461.88M | 241.54M | 255.95M | 335.17M |
| Free Cash Flow | -2.01B | 292.24M | -1.88B | -981.91M | -4.36B | -3.67B | 746.11M | -801.35M | 505.79M | 245.48M |
| FCF Growth % | -14.37% | 1.15% | -7.45% | 0.48% | -3.45% | 0.16% | 1.2% | -2.07% | 1.63% | -0.51% |
| FCF / Revenue % | - | - | - | - | - | - | - | - | - | - |
| Metric | 2015 | 2016 | 2017 | 2018 | 2019 | 2020 | 2021 | 2022 | 2023 | 2024 |
|---|---|---|---|---|---|---|---|---|---|---|
| FFO per Share | 0.97 | 1.24 | 1.2 | 3.16 | 1.24 | 1.33 | 1.68 | 2.08 | 0.1 | -3.26 |
| FFO Payout Ratio | 86.55% | 67.69% | 77.47% | 31.42% | 77.49% | 80.29% | 65.01% | 55.96% | 1031.65% | -16.41% |
| NOI Margin | 99.14% | 99.5% | 99.18% | 98.82% | 97.24% | 98.01% | 97.47% | 97.04% | 95.23% | 97.26% |
| Net Debt / EBITDA | 9.37x | 6.50x | 7.75x | 4.62x | 6.23x | 7.66x | 7.95x | 7.54x | 14.30x | 10.28x |
| Debt / Assets | 59.46% | 45.77% | 54.94% | 45.96% | 49.13% | 53.53% | 55.43% | 52.98% | 55.84% | 62.8% |
| Interest Coverage | 2.18x | 2.14x | 2.74x | 2.51x | 3.15x | - | 2.63x | 2.72x | 0.20x | 0.92x |
| Book Value / Share | 9.65 | 12.46 | 10.94 | 12.45 | 16.41 | 13.84 | 14.31 | 14.35 | 12.75 | 8.05 |
| Revenue Growth | 41.39% | 22.46% | 30.23% | 11.32% | 10.93% | 43.55% | 23.65% | -0.12% | -43.49% | 14.19% |
| 2013 | 2014 | 2015 | 2016 | 2017 | |
|---|---|---|---|---|---|
| UNITED STATES | - | - | - | 439.53M | 577.13M |
| UNITED STATES Growth | - | - | - | - | 31.31% |
| Other States | - | - | - | 187.36M | 235.54M |
| Other States Growth | - | - | - | - | 25.72% |
| GERMANY | - | - | 78.54M | 97.38M | 123.45M |
| GERMANY Growth | - | - | - | 23.99% | 26.77% |
| MASSACHUSETTS | - | - | - | 26.1M | 107.19M |
| MASSACHUSETTS Growth | - | - | - | - | 310.74% |
| TEXAS | - | - | 87.54M | 96.99M | 102.93M |
| TEXAS Growth | - | - | - | 10.80% | 6.12% |
| CALIFORNIA | - | - | 66.12M | 66.2M | 66.24M |
| CALIFORNIA Growth | - | - | - | 0.12% | 0.07% |
| ARIZONA | - | - | - | 23.8M | 36.39M |
| ARIZONA Growth | - | - | - | - | 52.92% |
| UTAH | - | - | - | - | 28.83M |
| UTAH Growth | - | - | - | - | - |
| Flagstaff Arizona | - | - | - | - | 21.79M |
| Flagstaff Arizona Growth | - | - | - | - | - |
| Birmingham UK | - | - | - | - | 14.69M |
| Birmingham UK Growth | - | - | - | - | - |
| Idaho Falls Id | - | - | - | - | 11.21M |
| Idaho Falls Id Growth | - | - | - | - | - |
| Italy Spain and United Kingdom | - | - | 4.48M | 4.22M | 4.16M |
| Italy Spain and United Kingdom Growth | - | - | - | -5.65% | -1.47% |
| NEW JERSEY | - | - | - | 39.08M | - |
| NEW JERSEY Growth | - | - | - | - | - |
| Europe | - | 26M | - | - | - |
| Europe Growth | - | - | - | - | - |
| Property Four | 16.39M | - | - | - | - |
| Property Four Growth | - | - | - | - | - |
| Property Eight | 16.32M | - | - | - | - |
| Property Eight Growth | - | - | - | - | - |
Medical Properties Trust, Inc. (MPW) reported $936.9M in revenue for fiscal year 2024. This represents a 608% increase from $132.3M in 2011.
Medical Properties Trust, Inc. (MPW) grew revenue by 14.2% over the past year. This is steady growth.
Medical Properties Trust, Inc. (MPW) reported a net loss of $707.4M for fiscal year 2024.
Yes, Medical Properties Trust, Inc. (MPW) pays a dividend with a yield of 10.37%. This makes it attractive for income-focused investors.
Medical Properties Trust, Inc. (MPW) has a return on equity (ROE) of -38.7%. Negative ROE indicates the company is unprofitable.
Medical Properties Trust, Inc. (MPW) generated Funds From Operations (FFO) of $-463.1M in the trailing twelve months. FFO is the primary profitability metric for REITs.
Medical Properties Trust, Inc. (MPW) offers a 10.37% dividend yield, which is attractive for income investors. REITs are required to distribute at least 90% of taxable income to shareholders.